Discovery of Preclinical Candidate AD1058 as a Highly Potent, Selective, and Brain-Penetrant ATR Inhibitor for the Treatment of Advanced Malignancies
2024 · Journal of Medicinal Chemistry · 12 citations
https://doi.org/10.1021/acs.jmedchem.4c00734
K
Kai Long
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
2.1K
Citations
13
h-index
15
i10-index
Kai Long is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Endoplasmic Reticulum Stress and Disease & Parkinson's Disease Mechanisms and Treatments & Cancer-related molecular mechanisms research. The author has an h-index of 13, co-authored 21 publications.
Papers by this author
worksHcCnAα regulates NF-κB signaling in Hyriopsis cumingii by interacting with HcIKK and facilitating IκB phosphorylation
2024 · International Journal of Biological Macromolecules · 2 citations
https://doi.org/10.1016/j.ijbiomac.2024.138787
Author Correction: Extraordinarily potent proinflammatory properties of lactoferrin-containing immunocomplexes against human monocytes and macrophages
2018 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-018-35598-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat